IDH2 and central nervous system cancer: In gliomas carrying mutations in genes encoding isocitrate dehydrogenase 1 (IDH1) or 2 (IDH2), microglia-derived TAMs are more dominant compared to wild-type gliomas (Friebel et al., 2020).